期刊文献+

血管生成素与绿色荧光蛋白融合蛋白的表达及纯化

Expression and purification of angiogenin-EGFP fusion protein in E.coli
在线阅读 下载PDF
导出
摘要 目的:表达并纯化血管生成素(ANG)与增强型绿色荧光蛋白(EGFP)融合蛋白,以进一步探讨血管生成素的生物学功能。方法:PCR扩增人ANG基因,将其与EGFP基因融合后克隆到高表达载体pMFHT,构建了原核表达质粒pHIS鄄ANG鄄EGFP。该质粒转化大肠杆菌BL21(DE3),IPTG诱导表达,并用金属螯合亲和层析纯化目的蛋白。激光共聚焦显微镜和Westernblot鉴定融合蛋白的表达情况。结果:重组蛋白在大肠杆菌中得到高效表达,并从破菌上清中一步纯化目的蛋白,纯度可达95%以上。Westernblot分析表明表达产物具有良好的抗原性和特异性。诱导表达的菌体在激光共聚焦显微镜下可发射明亮的绿色荧光。结论:成功的表达并纯化了ANG鄄EGFP融合蛋白,利用EGFP的荧光示踪作用,该融合蛋白可用于血管生成素核转位和胞内共定位蛋白质研究。 Objective: To express and purify fusion protein from angiogenin(ANG) and enhanced green fluorescent protein (EGFP) to further study the function of angiogenin. Methods: Human angiogenin gene was amplified by PCR and fused with EGFP. The fusion gene was inserted into the prokaryotic expression vector pMFHT to construct recombinant expression plasmid pHIS-ANG-EGFP. The recombinant plasmid was transformed into E.coli BL21(DE3) to express fusion protein under IPTG induction. The target protein was purified by Ni-NTA affinity chromatography. The induced bacteria were observed by confocal laser scanning microscope, and the purified protein was tested by Western blotting. Results: The fusion protein was highly expressed in E.coli, and then the target protein was purified in one step to 95% of purity from bacterial supernatant by Ni-NTA affinity chromatography. Western blotting assay demonstrated the expressed ANG-EGFP had good antigenicity and high specificity. Moreover, the induced bacteria could emit bright green fluorescence by confocal laser scanning microscope. Conclusion: The successful expression and purification of ANG-EGFP fusion protein provides materials to clarify the process of nuclear translocation of angiogenin and to explore its mechanism of action in RNA transcription.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2005年第7期437-442,共6页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金资助项目(30171035)
关键词 血管生成素 增强型绿色荧光蛋白 免疫印迹分析 金属螯合亲和层析 融合表达 angiogenin enhanced green fluorescent protein Western blotting Ni-NTA affinity chromatography fusion expression
  • 相关文献

参考文献13

  • 1Ryan CJ, Wilding G. Angiogenesis inhibitors. New agents in cancer therapy [J]. Drugs Aging, 2000, 17(4):249-255.
  • 2Zogakis TG,Libutti SK.General aspects of antiangiogenesis and cancer therapy [J]. Expert Opin Biol Ther, 2001, 1(2):253-275.
  • 3Stoeltzing O, Liu W, Reinmuth N, et al. Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis[J]. Ann Surg Oncol, 2003, 10(7):722-733.
  • 4Fett JW, Strydom DJ, Lobb RR, et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells [J]. Biochemistry, 1985, 24:5480-5486.
  • 5Folkman J, Klagsbrun M. Angiogenic factors [J]. Science,1987, 235: 442-447.
  • 6Liu S, Yu D, Xu ZP, et al. Angiogenin activates Erk1/2 in human umbilical vein endothelial cells [J]. Biochem Biophys Res Commun, 2001, 287: 305-310.
  • 7Xu ZP, Monti DM, Hu GF. Angiogenin activates human umbilical artery smooth muscle cells [J]. Biochem Biophys Res Commun, 2001, 285(4):909-914.
  • 8Riordan JF. Angiogenin[J ]. Methods Enzymol, 2001, 341:263-273.
  • 9Hu GF, Xu CJ,Riordan JF. Human angiogenin is rapidly translocated to the nucleus of human umbilical vein endothelial cells and binds to DNA [J ]. J Cell Biochem,2000, 76: 452-462.
  • 10Laduron PM. From receptor internalization to nuclear translocation: New targets for long-term pharmacology [J].Biochem Pharmacol, 1994,47(1):3-13.

二级参考文献17

  • 1Fett JW, Strydom D J, Lobb RR, Alderman EM, Bethune JL,Riordan JF, Vallee BL. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry, 1985, 24(20): 5480 - 5486.
  • 2Folkman J, Klagsbrun M. Angiogenic factors. Science,1987,235(4787): 442 -447.
  • 3Liu S, Yu D, Xu Z, Riordan JF, Hu G. Angiogenin activates Erk1/2 in human umbilical vein endothelial cells. Biochem Biophys Res Cornmun, 2001,287(1 ): 305 -310.
  • 4Riordan JF. In: D' Alessio G, Riordan JF eds. Ribonuclease:Structures and Functions. New York: Academic Press, 1997,445 - 489.
  • 5Riordan JF. Angiogenin. Methods Enzyrnol, 2001,341 : 263 -273.
  • 6Hu G, Xu C, Riordan JF. Human angiogenin is rapidly translocated to the nucleus of human umbilical vein endothelial cells and binds to DNA. J Cell Biochem, 2000, 76(3): 452 -462.
  • 7Laduron PM. From receptor internalization to nuclear translocation: New targets for iong-term pharmacology. Biochem Pharmacol, 1994, 47(1 ): 3 - 13.
  • 8Shapiro R, Harper JW, Fox EA, Jansen HW, Hein F, Uhlmann E. Expression of Met-(-1 ) angiogenin in Escherichia coli: Conversion to the authentic less than Glu-1 protein. Anal Biochem, 1988, 175(2): 450 -461.
  • 9Kao RY, Jenkins JL, Olson KA, Key ME, Fett JW, Shapiro R. A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity. Proc Natl Acad Sci USA, 2002, 99(15): 10066 -10071.
  • 10Bouche G, Gas N, Prats H, Baldin V, Tauber JP, Teissie J,Amalric F. Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0 - G1 transition. Proc Natl Acad Sci USA,1987, 84(19): 6770 - 6774.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部